(Q42275853)
Statements
A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 results (English)
Andrew Zolopa
Edwin DeJesus
Calvin Cohen
David Wohl
Joel E Gallant
Hui C Liu
Andrew Plummer
Kirsten L White
Andrew K Cheng
Martin S Rhee
Javier Szwarcberg
GS-US-236-0102 Study Team